共 50 条
- [31] n-3 fatty acids and ventricular arrhythmias in patients with ischaemic heart disease and implantable cardioverter defibrillators EUROPACE, 2005, 7 (04): : 338 - 344
- [32] Impact of the COVID-19 lockdown on the arrhythmic burden of patients with implantable cardioverter-defibrillators PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2021, 44 (06): : 1033 - 1038
- [34] Impact of Implantable Cardioverter Defibrillators on Survival of Patients with Centrifugal Left Ventricular Assist Devices PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2015, 38 (08): : 925 - 933
- [38] Characteristics and Outcomes of Patients Receiving New and Replacement Implantable Cardioverter-Defibrillators: Results From the NCDR CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2013, 6 (04): : 488 - 497
- [39] Anxiety and Risk of Ventricular Arrhythmias or Mortality in Patients With an Implantable Cardioverter Defibrillator PSYCHOSOMATIC MEDICINE, 2013, 75 (01): : 36 - 41